ACCA Media Release: Pfizer Vaccine Reason for Optimism in Continuing Care

Dec 15, 2020

Edmonton, AB: For Immediate Release


The Alberta Continuing Care Association (ACCA) welcomes the good news of the arrival of the COVID-19 vaccine from Pfizer, as well as the administration of the vaccine to eligible designated supportive living and long-term care employees as part of the Phase 1 priority vaccination process. This is an important step in protecting vulnerable residents and those who care for them.

The vaccine is a reason for optimism for care providers, residents, family members and staff. There is, however, further discussion needed on the following items regarding prioritization and implementation:

• All staff and residents at highest risk should be vaccinated in Phase 1 to help prevent possible transmission. This should include all residents and staff in Home Care, all levels of supportive living, as well as Long Term Care.

• The logistics regarding the Pfizer vaccine timing and administration for continuing care residents and staff will need to be confirmed.

The ACCA looks forward to further collaboration with the provincial government, Alberta Health Services and Alberta Health to assist with the immunization of all those living or working in continuing care and to take the steps necessary to protect vulnerable Albertans. 


Contact: Wayne Morishita, Executive Director, ACCA, wayne.morishita@ab-cca.ca